vs

Side-by-side financial comparison of CBL & ASSOCIATES PROPERTIES INC (CBL) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

CBL & ASSOCIATES PROPERTIES INC is the larger business by last-quarter revenue ($156.4M vs $138.3M, roughly 1.1× Core Laboratories Inc.). CBL & ASSOCIATES PROPERTIES INC runs the higher net margin — 31.3% vs 5.3%, a 26.1% gap on every dollar of revenue. On growth, CBL & ASSOCIATES PROPERTIES INC posted the faster year-over-year revenue change (18.8% vs 2.8%). Over the past eight quarters, CBL & ASSOCIATES PROPERTIES INC's revenue compounded faster (10.1% CAGR vs 2.9%).

CBL & Associates Properties, Inc. is an American real estate investment trust that invests in shopping centers and shopping malls, primarily in the Southeastern and Midwestern United States. The company is organized in Delaware with its headquarters in Chattanooga, Tennessee. Its largest market is Chattanooga, Tennessee. The company's name is based on the initials of its founder, Charles B. Lebovitz.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

CBL vs CLB — Head-to-Head

Bigger by revenue
CBL
CBL
1.1× larger
CBL
$156.4M
$138.3M
CLB
Growing faster (revenue YoY)
CBL
CBL
+16.0% gap
CBL
18.8%
2.8%
CLB
Higher net margin
CBL
CBL
26.1% more per $
CBL
31.3%
5.3%
CLB
Faster 2-yr revenue CAGR
CBL
CBL
Annualised
CBL
10.1%
2.9%
CLB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CBL
CBL
CLB
CLB
Revenue
$156.4M
$138.3M
Net Profit
$49.0M
$7.3M
Gross Margin
Operating Margin
11.5%
Net Margin
31.3%
5.3%
Revenue YoY
18.8%
2.8%
Net Profit YoY
29.0%
1.2%
EPS (diluted)
$1.61
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBL
CBL
CLB
CLB
Q1 26
$138.3M
Q4 25
$156.4M
$138.3M
Q3 25
$139.3M
$134.5M
Q2 25
$140.9M
$130.2M
Q1 25
$141.8M
$123.6M
Q4 24
$131.7M
$129.2M
Q3 24
$125.1M
$134.4M
Q2 24
$129.7M
$130.6M
Net Profit
CBL
CBL
CLB
CLB
Q1 26
$7.3M
Q4 25
$49.0M
$4.9M
Q3 25
$75.4M
$14.2M
Q2 25
$2.8M
$10.6M
Q1 25
$8.8M
$-154.0K
Q4 24
$38.0M
$7.4M
Q3 24
$16.2M
$11.7M
Q2 24
$4.7M
$9.0M
Gross Margin
CBL
CBL
CLB
CLB
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CBL
CBL
CLB
CLB
Q1 26
11.5%
Q4 25
11.5%
Q3 25
15.6%
Q2 25
11.7%
Q1 25
3.6%
Q4 24
11.0%
Q3 24
14.7%
Q2 24
12.3%
Net Margin
CBL
CBL
CLB
CLB
Q1 26
5.3%
Q4 25
31.3%
3.6%
Q3 25
54.2%
10.6%
Q2 25
2.0%
8.2%
Q1 25
6.2%
-0.1%
Q4 24
28.8%
5.7%
Q3 24
12.9%
8.7%
Q2 24
3.7%
6.9%
EPS (diluted)
CBL
CBL
CLB
CLB
Q1 26
$0.16
Q4 25
$1.61
$0.11
Q3 25
$2.38
$0.30
Q2 25
$0.08
$0.22
Q1 25
$0.27
$0.00
Q4 24
$1.22
$0.15
Q3 24
$0.52
$0.25
Q2 24
$0.14
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBL
CBL
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$42.3M
$22.8M
Total DebtLower is stronger
$2.2B
Stockholders' EquityBook value
$374.9M
$279.8M
Total Assets
$2.7B
$597.0M
Debt / EquityLower = less leverage
5.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBL
CBL
CLB
CLB
Q1 26
$22.8M
Q4 25
$42.3M
$22.7M
Q3 25
$52.6M
$25.6M
Q2 25
$100.3M
$31.2M
Q1 25
$100.3M
$22.1M
Q4 24
$40.8M
$19.2M
Q3 24
$65.1M
$21.5M
Q2 24
$57.7M
$17.7M
Total Debt
CBL
CBL
CLB
CLB
Q1 26
Q4 25
$2.2B
$110.3M
Q3 25
$2.2B
$114.1M
Q2 25
$2.1B
$124.6M
Q1 25
$2.2B
$124.4M
Q4 24
$2.2B
$126.1M
Q3 24
$1.8B
$139.9M
Q2 24
$1.9B
$147.6M
Stockholders' Equity
CBL
CBL
CLB
CLB
Q1 26
$279.8M
Q4 25
$374.9M
$266.0M
Q3 25
$351.4M
$271.3M
Q2 25
$289.4M
$261.3M
Q1 25
$295.0M
$253.4M
Q4 24
$323.5M
$246.6M
Q3 24
$308.3M
$250.7M
Q2 24
$308.8M
$240.3M
Total Assets
CBL
CBL
CLB
CLB
Q1 26
$597.0M
Q4 25
$2.7B
$584.0M
Q3 25
$2.7B
$591.4M
Q2 25
$2.6B
$602.1M
Q1 25
$2.6B
$591.5M
Q4 24
$2.7B
$585.1M
Q3 24
$2.2B
$600.5M
Q2 24
$2.3B
$597.8M
Debt / Equity
CBL
CBL
CLB
CLB
Q1 26
Q4 25
5.79×
0.41×
Q3 25
6.21×
0.42×
Q2 25
7.39×
0.48×
Q1 25
7.29×
0.49×
Q4 24
6.84×
0.51×
Q3 24
5.76×
0.56×
Q2 24
6.00×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBL
CBL
CLB
CLB
Operating Cash FlowLast quarter
$249.7M
$37.2M
Free Cash FlowOCF − Capex
$5.1M
FCF MarginFCF / Revenue
3.7%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
5.10×
5.12×
TTM Free Cash FlowTrailing 4 quarters
$27.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBL
CBL
CLB
CLB
Q1 26
$37.2M
Q4 25
$249.7M
$7.9M
Q3 25
$69.6M
$8.5M
Q2 25
$68.3M
$13.9M
Q1 25
$31.7M
$6.7M
Q4 24
$202.2M
$20.6M
Q3 24
$61.1M
$13.1M
Q2 24
$64.2M
$17.1M
Free Cash Flow
CBL
CBL
CLB
CLB
Q1 26
$5.1M
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$46.0M
$10.4M
Q2 24
$54.8M
$14.3M
FCF Margin
CBL
CBL
CLB
CLB
Q1 26
3.7%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
36.8%
7.7%
Q2 24
42.2%
10.9%
Capex Intensity
CBL
CBL
CLB
CLB
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
12.1%
2.0%
Q2 24
7.3%
2.2%
Cash Conversion
CBL
CBL
CLB
CLB
Q1 26
5.12×
Q4 25
5.10×
1.61×
Q3 25
0.92×
0.60×
Q2 25
24.74×
1.31×
Q1 25
3.60×
Q4 24
5.32×
2.78×
Q3 24
3.77×
1.12×
Q2 24
13.54×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons